Aditya Sardesai

Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model

Alexia Kieffer, Matthieu Beuvelet, Aditya Sardesai et al. · The Journal of Infectious Diseases · 2022 · 75 citations · Full text

A Path to Improved Alzheimer’s Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer’s Disease from the CLARITY AD Trial

Amir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai et al. · Neurology and Therapy · 2023 · 33 citations · Full text

Estimated Societal Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling

Amir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai et al. · Neurology and Therapy · 2023 · 19 citations · Full text

Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation

Ataru Igarashi, Mie Azuma, Quanwu Zhang et al. · Neurology and Therapy · 2023 · 17 citations · Full text

Cost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in Germany

Aditya Sardesai, Peter Quon, Sandra Milev et al. · Journal of Medical Economics · 2021 · 14 citations · Full text